Bioelectrical Impedance Phase Angle and Morbidity and Mortality in Critically Ill Children

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorZAMBERLAN, Patricia
dc.contributor.authorFEFERBAUM, Rubens
dc.contributor.authorDORIA FILHO, Ulysses
dc.contributor.authorCARVALHO, Werther Brunow de
dc.contributor.authorDELGADO, Artur Figueiredo
dc.date.accessioned2019-03-26T14:30:56Z
dc.date.available2019-03-26T14:30:56Z
dc.date.issued2019
dc.description.abstractBackgroundNutrition markers may be useful for diagnosis and monitoring and, also, as additional indicators of estimating death risk. We tested the association of body composition indicators (mid-upper arm circumference and phase angle) with pediatric intensive care unit (PICU) length of stay and mortality in critically ill pediatric patients. MethodsData from children aged 2 months-18 years were collected, and bioelectrical impedance was performed to obtain phase angle. Severity was evaluated by scoring the Pediatric Index of Mortality. Descriptive statistics were reported for nominal variables. Receiver operating characteristic curve was used to analyze the association of phase angle with 30-day mortality and to find the best cutoff. Survival probabilities and PICU length of stay were estimated using the Kaplan-Meier method. ResultsWe evaluated 247 children with a median age of 4.8 years whose main cause of admission was sepsis. Survival curves showed higher survival in patients with phase angle >2.8 degrees compared with patients with phase angle 2.8 degrees (P<.0001). Kaplan-Meier time-to-event analysis showed that children with lower phase angle values were more likely to remain in the PICU (hazard ratio, 1.84; P=.003). Lower survival was also observed in patients who presented mid-upper arm circumference values 5th percentile (P<.03). ConclusionsMid-upper arm circumference and phase angle were associated with mortality and morbidity in critically ill children, suggesting that these parameters may be useful not only for nutrition diagnosis and monitoring, but also as an additional indicator in estimating prognosis.eng
dc.description.indexMEDLINEeng
dc.identifier.citationNUTRITION IN CLINICAL PRACTICE, v.34, n.1, p.163-171, 2019
dc.identifier.doi10.1002/ncp.10201
dc.identifier.eissn1941-2452
dc.identifier.issn0884-5336
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/31189
dc.language.isoeng
dc.publisherWILEYeng
dc.relation.ispartofNutrition in Clinical Practice
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright WILEYeng
dc.subjectbody compositioneng
dc.subjectelectrical impedanceeng
dc.subjectmortalityeng
dc.subjectnutrition assessmenteng
dc.subjectpediatric intensive care unitseng
dc.subjectphase angleeng
dc.subjectprognosiseng
dc.subject.otherbody-mass indexeng
dc.subject.otherfat-free masseng
dc.subject.othernutritional-statuseng
dc.subject.otherclinical-outcomeseng
dc.subject.othermalnutritioneng
dc.subject.otheradmissioneng
dc.subject.otherpredictoreng
dc.subject.othercancereng
dc.subject.otherparameterseng
dc.subject.otherstatureeng
dc.subject.wosNutrition & Dieteticseng
dc.titleBioelectrical Impedance Phase Angle and Morbidity and Mortality in Critically Ill Childreneng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus22
hcfmusp.contributor.author-fmusphcPATRICIA ZAMBERLAN DOS SANTOS
hcfmusp.contributor.author-fmusphcRUBENS FEFERBAUM
hcfmusp.contributor.author-fmusphcULYSSES DORIA FILHO
hcfmusp.contributor.author-fmusphcWERTHER BRUNOW DE CARVALHO
hcfmusp.contributor.author-fmusphcARTUR FIGUEIREDO DELGADO
hcfmusp.description.beginpage163
hcfmusp.description.endpage171
hcfmusp.description.issue1
hcfmusp.description.volume34
hcfmusp.origemWOS
hcfmusp.origem.pubmed30303570
hcfmusp.origem.scopus2-s2.0-85054681441
hcfmusp.origem.wosWOS:000459619900018
hcfmusp.publisher.cityHOBOKENeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAzevedo ZMA, 2013, CLIN NUTR, V32, P824, DOI 10.1016/j.clnu.2013.01.011eng
hcfmusp.relation.referenceAlves FD, 2016, CLIN NUTR, V35, P1530, DOI 10.1016/j.clnu.2016.04.007eng
hcfmusp.relation.referenceBarbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39eng
hcfmusp.relation.referenceBarbosa-Silva MCG, 2003, NUTRITION, V19, P422, DOI 10.1016/S0899-9007(02)00932-2eng
hcfmusp.relation.referenceBechard LJ, 2016, CRIT CARE MED, V44, P1530, DOI 10.1097/CCM.0000000000001713eng
hcfmusp.relation.referenceBelarmino G, 2017, WORLD J HEPATOL, V9, P401, DOI 10.4254/wjh.v9.i7.401eng
hcfmusp.relation.referenceBriassoulis G, 2014, INTENS CARE MED, V40, P120, DOI 10.1007/s00134-013-3123-5eng
hcfmusp.relation.referenceChomtho S, 2006, PEDIATR RES, V59, P860, DOI 10.1203/01.pdr.0000219395.83159.91eng
hcfmusp.relation.referenceCHUMLEA WMC, 1994, J AM DIET ASSOC, V94, P1385, DOI 10.1016/0002-8223(94)92540-2eng
hcfmusp.relation.referenceCraig E, 2014, ARCH DIS CHILD, V99, P763, DOI 10.1136/archdischild-2013-305137eng
hcfmusp.relation.referencede Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548eng
hcfmusp.relation.referenceDelgado AF, 2008, CLINICS, V63, P357, DOI 10.1590/S1807-59322008000300012eng
hcfmusp.relation.referenceFeferbaum R, 2009, CURR OPIN CLIN NUTR, V12, P245, DOI 10.1097/MCO.0b013e32832a3f43eng
hcfmusp.relation.referenceFoster KR, 1996, AM J CLIN NUTR, V64, P388eng
hcfmusp.relation.referenceFRISANCHO AR, 1974, AM J CLIN NUTR, V27, P1052eng
hcfmusp.relation.referenceFrisancho AR., 1999, ANTHROPOMETRIC STANDeng
hcfmusp.relation.referenceGramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003eng
hcfmusp.relation.referenceGrippa RB, 2017, NUTRITION, V33, P91, DOI 10.1016/j.nut.2016.05.002eng
hcfmusp.relation.referenceHulst J, 2004, CLIN NUTR, V23, P223, DOI 10.1016/S0261-5614(03)00130-4eng
hcfmusp.relation.referenceIsraels T, 2008, PEDIATR BLOOD CANCER, V51, P626, DOI 10.1002/pbc.21697eng
hcfmusp.relation.referenceJohansen KL, 2003, AM J CLIN NUTR, V77, P842eng
hcfmusp.relation.referenceKyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012eng
hcfmusp.relation.referenceKyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004eng
hcfmusp.relation.referenceKyle UG, 2013, CLIN NUTR, V32, P294, DOI 10.1016/j.clnu.2012.08.001eng
hcfmusp.relation.referenceLeite HP, 2016, PEDIATR CRIT CARE ME, V17, pE50, DOI 10.1097/PCC.0000000000000596eng
hcfmusp.relation.referenceLUKASKI HC, 1985, AM J CLIN NUTR, V41, P810eng
hcfmusp.relation.referenceMauricio SF, 2016, NUTR CANCER, V68, P949, DOI 10.1080/01635581.2016.1188971eng
hcfmusp.relation.referenceMenezes FD, 2012, NUTRITION, V28, P267, DOI 10.1016/j.nut.2011.05.015eng
hcfmusp.relation.referenceMoisey LL, 2013, CRIT CARE, V17, DOI 10.1186/cc12901eng
hcfmusp.relation.referenceNorman K, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.024eng
hcfmusp.relation.referenceNorman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008eng
hcfmusp.relation.referenceOng C, 2014, CLIN NUTR, V33, P191, DOI 10.1016/j.clnu.2013.12.010eng
hcfmusp.relation.referenceCamargo DAP, 2017, NUTR CANCER, V69, P601, DOI 10.1080/01635581.2017.1299880eng
hcfmusp.relation.referencePichard C, 2004, AM J CLIN NUTR, V79, P613eng
hcfmusp.relation.referenceRavasco P, 2002, CLIN NUTR, V21, P73, DOI 10.1054/clnu.2001.0508eng
hcfmusp.relation.referenceReilly JJ, 2017, ARCH DIS CHILD, V102, P1, DOI 10.1136/archdischild-2016-311682eng
hcfmusp.relation.referenceRuiz-Margain A, 2015, DIGEST LIVER DIS, V47, P309, DOI 10.1016/j.dld.2014.12.015eng
hcfmusp.relation.referenceShann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317eng
hcfmusp.relation.referenceSoler-Cataluna JJ, 2005, CHEST, V128, P2108, DOI 10.1378/chest.128.4.2108eng
hcfmusp.relation.referenceSTEVENSON RD, 1995, ARCH PEDIAT ADOL MED, V149, P658, DOI 10.1001/archpedi.1995.02170190068012eng
hcfmusp.relation.referenceStobaus N, 2012, BRIT J NUTR, V107, P1217, DOI 10.1017/S0007114511004028eng
hcfmusp.relation.referenceStratton RJ, 2007, EUR J GASTROEN HEPAT, V19, P353, DOI 10.1097/MEG.0b013e32801055c0eng
hcfmusp.relation.referenceThibault R, 2016, INTENS CARE MED, V42, P1445, DOI 10.1007/s00134-016-4468-3eng
hcfmusp.relation.referenceWeijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/cc13189eng
hcfmusp.relation.referenceZamberlan P, 2011, JPEN-PARENTER ENTER, V35, P523, DOI 10.1177/0148607110386610eng
hcfmusp.scopus.lastupdate2024-06-14
relation.isAuthorOfPublicationce6f44e1-30b7-42b3-aa55-56a1fdadf3ec
relation.isAuthorOfPublicationb1b29c94-ecb2-4a2a-99ae-4e02ea692c3d
relation.isAuthorOfPublicationa20d0297-460f-4554-b20a-9bae686fc6ff
relation.isAuthorOfPublication2baaab86-163c-4798-b170-4a2f0d798e52
relation.isAuthorOfPublication835395d3-fbe2-4563-9ffe-38f54536c37b
relation.isAuthorOfPublication.latestForDiscoveryce6f44e1-30b7-42b3-aa55-56a1fdadf3ec
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_ZAMBERLAN_Bioelectrical_Impedance_Phase_Angle_and_Morbidity_and_Mortality_2019.PDF
Tamanho:
1.09 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/36